Assessing Treatment Outcomes of Patients Undergoing Enfortumab Vedotin Dose Reduction in Metastatic Bladder Cancer

Clinical Genitourinary Cancer 2026

View at publisher
Authors: Hal Rives, Jordan D. Fredette, Fern M. Anari, Pooja Ghatalia, Daniel Geynisman, Elizabeth R. Plimack, Matthew R. Zibelman
DOI: 10.1016/j.clgc.2026.102525
Cited by: 1
References: 8

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary Bladder and Prostate Research Esophageal Cancer Research and Treatment

Publication details

Journal / source
Clinical Genitourinary Cancer
Publisher
Elsevier BV
Volume
24
Issue
4
Pages
102525–102525
Publication date
4 March 2026
Language
EN